TNFR1 inhibition with a Nanobody protects against EAE development in mice
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TNFR1 inhibition with a Nanobody protects against EAE development in mice
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-10-16
DOI
10.1038/s41598-017-13984-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Update on disease-modifying therapies for multiple sclerosis
- (2017) Diana L Vargas et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Nanobodies as therapeutics: big opportunities for small antibodies
- (2016) Sophie Steeland et al. DRUG DISCOVERY TODAY
- Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis
- (2016) Alice Valentin-Torres et al. Journal of Neuroinflammation
- Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination
- (2016) Pernille M. Madsen et al. JOURNAL OF NEUROSCIENCE
- Suppressive activity of human regulatory T cells is maintained in the presence of TNF
- (2016) Bruno Zaragoza et al. NATURE MEDICINE
- Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration
- (2016) Yun Dong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacokinetics and pharmacodynamics of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis in the randomized ADVANCE study
- (2015) Xiao Hu et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Amyloid Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases
- (2015) M. Brkic et al. JOURNAL OF NEUROSCIENCE
- Emerging immunopharmacological targets in multiple sclerosis
- (2015) Mojtaba Farjam et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Treatment of progressive multiple sclerosis: what works, what does not, and what is needed
- (2015) Anthony Feinstein et al. LANCET NEUROLOGY
- TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects
- (2015) L. Probert NEUROSCIENCE
- Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis
- (2014) Radu Tanasescu et al. Expert Opinion on Drug Metabolism & Toxicology
- Generation and Characterization of Small Single Domain Antibodies Inhibiting Human Tumor Necrosis Factor Receptor 1
- (2014) Sophie Steeland et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Altered Expression of Oligodendrocyte and Neuronal Marker Genes Predicts the Clinical Onset of Autoimmune Encephalomyelitis and Indicates the Effectiveness of Multiple Sclerosis-Directed Therapeutics
- (2014) M. Evangelidou et al. JOURNAL OF IMMUNOLOGY
- Antibody-Mediated Inhibition of TNFR1 Attenuates Disease in a Mouse Model of Multiple Sclerosis
- (2014) Sarah K. Williams et al. PLoS One
- Editorial: Balancing Tumor Necrosis Factor Receptor I and Tumor Necrosis Factor Receptor II Jointly for Joint Inflammation
- (2014) Bharat B. Aggarwal Arthritis & Rheumatology
- Selective Tumor Necrosis Factor Receptor I Blockade Is Antiinflammatory and Reveals Immunoregulatory Role of Tumor Necrosis Factor Receptor II in Collagen-Induced Arthritis
- (2014) Fiona E. McCann et al. Arthritis & Rheumatology
- Demyelination and other neurological adverse events after anti-TNF therapy
- (2013) Evripidis Kaltsonoudis et al. AUTOIMMUNITY REVIEWS
- Astrocyte-specific activation of TNFR2 promotes oligodendrocyte maturation by secretion of leukemia inhibitory factor
- (2013) Roman Fischer et al. GLIA
- Role of Regulatory T Cells in Pathogenesis and Biological Therapy of Multiple Sclerosis
- (2013) Milan Buc MEDIATORS OF INFLAMMATION
- Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS
- (2012) Jigisha R. Patel et al. ACTA NEUROPATHOLOGICA
- The Membrane Fusion Enigma: SNAREs, Sec1/Munc18 Proteins, and Their Accomplices—Guilty as Charged?
- (2012) Josep Rizo et al. Annual Review of Cell and Developmental Biology
- Molecular Mechanisms of Oligodendrocyte Injury in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
- (2012) Jilpa Patel et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CXCL1 can be regulated by IL-6 and promotes granulocyte adhesion to brain capillaries during bacterial toxin exposure and encephalomyelitis
- (2012) Monica Roy et al. Journal of Neuroinflammation
- Matrix Metalloprotease 8-Dependent Extracellular Matrix Cleavage at the Blood-CSF Barrier Contributes to Lethality during Systemic Inflammatory Diseases
- (2012) R. E. Vandenbroucke et al. JOURNAL OF NEUROSCIENCE
- TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
- (2012) Adam P. Gregory et al. NATURE
- Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation
- (2012) Dimitrios Davalos et al. Nature Communications
- Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination
- (2011) Roberta Brambilla et al. BRAIN
- Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-κB
- (2011) Era Taoufik et al. BRAIN
- Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1
- (2011) Filip Van Hauwermeiren et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Pathogenic and Protective Functions of TNF in Neuroinflammation Are Defined by Its Expression in T Lymphocytes and Myeloid Cells
- (2011) A. A. Kruglov et al. JOURNAL OF IMMUNOLOGY
- Ligand-induced internalization of TNF receptor 2 mediated by a di-leucin motif is dispensable for activation of the NFκB pathway
- (2010) Roman Fischer et al. CELLULAR SIGNALLING
- T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
- (2010) J. M. Fletcher et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+regulatory T cells in human peripheral blood
- (2010) Xin Chen et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination
- (2010) Jens Watzlawik et al. Expert Review of Neurotherapeutics
- Expression of Costimulatory TNFR2 Induces Resistance of CD4+FoxP3- Conventional T Cells to Suppression by CD4+FoxP3+ Regulatory T Cells
- (2010) X. Chen et al. JOURNAL OF IMMUNOLOGY
- Astrocytes promote TNF-mediated toxicity to oligodendrocyte precursors
- (2010) SunJa Kim et al. JOURNAL OF NEUROCHEMISTRY
- Myelination and support of axonal integrity by glia
- (2010) Klaus-Armin Nave NATURE
- Therapeutic effect of PEGylated TNFR1-selective antagonistic mutant TNF in experimental autoimmune encephalomyelitis mice
- (2009) Tetsuya Nomura et al. JOURNAL OF CONTROLLED RELEASE
- The evolution of Olig genes and their roles in myelination
- (2009) Huiliang Li et al. Neuron Glia Biology
- Regulatory T Cells and Immune Tolerance
- (2008) Shimon Sakaguchi et al. CELL
- TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease
- (2008) Melissa K McCoy et al. Journal of Neuroinflammation
- TNFα blockade in human diseases: Mechanisms and future directions
- (2007) Maida Wong et al. CLINICAL IMMUNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started